IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Medico Remedies Ltd.
Issue Open Date 29-Jan-18  
Issue Closing Date 31-Jan-18  
Application Money 100  
Allotment Money  
Price Band 100 -  
Minimium Application No. 1200  
Issue Size (Shares) 1099200  
Market Lot 1.00  
Objective
The Objects of the Fresh Issue is to raise funds for:(a) Repayment of loans.(b) Funding expenditure for General Corporate Purposes.(c) Issue related expenses.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors       NA  
Qualified Institutional Buyers       NA  
Retail Individual Investors       NA  
Business Description
Our Company, Medico Remedies Limited, is a pharmaceutical formulation manufacturing company withmanufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins,antimalarial, antiretroviral, anti-ulcer drugs an
more...
Promoter's Holding
Total Share Capital   3192860  
Offered to Public   1099200  
Promoter's Holding (Pre-Issue)   99.78  
Promoter's Holding (Post-Issue)   73.34  
Address
1105/1106
11th Floor
Hubtown Solaris
Opp Telli Galli
N S Phadke Marg
Andheri East
Mumbai ,
Maharashtra ,
400069
Phone: 022 26821054 / 1055 / 26837116
Email: medicoremedies@yahoo.com / info@medicoremedies.com
Website: www.medicoremediesindia.com / www.medicoremediesindia.net / www.tabletandcapsules.com
Registrar
Cameo Corporate Services Ltd
Subramanian Buildings No 1
Club House Road

Chennai
Listed at
BSE
Lead Manager
Aryaman Financial Services Ltd.
Promoters
Haresh Mehta
Harshit Mehta
Rita Mehta
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.